Literature DB >> 30478657

Feasibility of simultaneous dual isotope acquisition for myocardial perfusion imaging with a cadmium zinc telluride camera.

Bernard Songy1, Mohamed Guernou2, David Lussato2, Mathieu Queneau2, Gerald Bonardel2, Jean-François Grellier2, Ludovic Flahaut2, Duc Nguyen2.   

Abstract

BACKGROUND: We studied the impact of technetium-99m (99mTc) in the thallium-201 (201Tl) energy window (70 keV) to determine if CZT cardiac cameras allow us to perform simultaneous dual-isotope acquisition for myocardial perfusion imaging.
METHODS: We included 117 consecutive patients. We injected 0.7 MBq/kg of 201Tl at stress, performed the first scan (image T1), then injected at rest 2 MBq/kg of 99mTc-tetrofosmin and immediately acquired a second scan with reconstruction in the energy window of thallium (image T2). A corrected thallium image was created by the subtraction of 99mTc downscattered photons (image TS). We compared spectra, image quality, and semiquantitative scores on T1, T2, and TS images.
RESULTS: Though T2 images were of worse quality, TS images were of equal quality compared to T1 images in most cases. Scores show an underestimation of abnormalities in 20% of patients on T2 images and in 10% on TS images.
CONCLUSIONS: Despite the improved energy resolution of CZT cameras, downscatter of technetium in the 201Tl window leads to an underestimation of the pathological territory in 10% to 20% of cases. It does not allow us to use simultaneous dual-isotope acquisition in clinical practice without additional tools for scatter correction.

Entities:  

Keywords:  CZT camera; Myocardial perfusion imaging; Simultaneous dual-isotope; Technetium-99m; Thallium-201

Year:  2018        PMID: 30478657     DOI: 10.1007/s12350-018-1452-z

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  1 in total

1.  Simultaneous dual-tracer 99mTc-tetrofosmin and 123I-BMIPP acquisition with CZT for ischemic memory: The future approaches to image the past.

Authors:  Carmela Nappi; Valeria Gaudieri; Mario Petretta
Journal:  J Nucl Cardiol       Date:  2019-01-30       Impact factor: 5.952

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.